The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac).
The New York Times: Zantac Products Should Not Be Sold or Used, F.D.A. Warns, Citing Cancer Danger
Popular Science: The FDA just pulled popular heartburn drug Zantac due to cancer risk
Apotheke Adhoc (Germany): USA: Ranitidin muss komplett zurück